Warning to be put in Avandia, Actos
Published: 2007-06-18 06:58:00
Updated: 2007-06-18 06:58:00
The Korea Food and Drug Administration said on June 12 that it instructed GlaxoSmithKline and Lilly Korea to add the warning to the instructions of Avandia and Actos, following widely publicized medical report that suggested it increases risk of heart attack.
Avandia, one of GSK biggest produc...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
